Members Area Login

Go to the login page

Want to be a Member?

Click here
Contact us
FAQ

IPEC Europe

Supporting the interests of pharmaceutical excipient developers, producers, distributors and users.

APV/IPEC Europe Excipient Conference 2018

 

Dear Colleagues,


IPEC Europe and APV are delighted to invite you to our 7th annual conference on pharmaceutical excipients.


The conference will focus on “hot topics” in the area of excipient regulation and technology.


As part of the programme we will offer three parallel workshops to provide practical, hands-on insight and discussion on regulatory topics, with a view to IPEC Guidelines providing tools to achieve compliance. These workshops will focus on implementation of GMP in an excipient manufacturing site, supplier qualification and auditing, as well as analytical data and certificates of analysis provided by suppliers of excipients.


Beyond that the regulatory session will highlight compendial topics of EDQM and USP. Challenges relating to the control of particulate contamination in excipients and requirements for excipients in parenteral applications will be presented and discussed by pharma industry experts.


The technical and scientific part of the conference will deal with the importance of excipient on drug bioavailability. Low bioavailability is most common with oral dosage forms of poorly water-soluble, slowly absorbed drugs. Lipid based drug delivery systems will be presented as they can be an approach to overcome low bioavailability.


The design of d rug rel eas e from modifi ed-release (MR) dosage for ms is intentionally diff erent from that of an immediate-release drug formulation to produce a desired therapeutic purpose or improved patient compliance. Here we will discuss a method to predict the modified release performance of drugs.


Molecules used as active drug substances can be categorised into two classes – small and large molecules. Small, chemically synthesised molecules are the conventional active substances and still constitute over 90 percent of the drugs available on the market today. Contrary to small molecules, large molecules are complex and often consist of heterogeneous mixtures; they are becoming increasingly important. We will highlight the role of excipients in small/large molecule drug formulation.


New scientific findings in the molecular processes of life are advancing our knowledge of health and disease. The objective of individualised medicine is to make such knowledge useful for individually tailored prevention, diagnosis and treatment. As new drugs are elaborated that have differential effects within populations, there is also a need to consider new manufacturing methods. The requirements of excipients for individualised medicines and continuous manufacturing processes will be pointed out.


Last but not least networking and exchange of information is a key feature of the e vent and table-top exhibitionsaligned to the conference will encourage communication between suppliers and users.

 

More information on the programme & registration here!

 

 

 

Newsletter Subscription

Sign up for our subscriber newsletter!